In line with this, MLL-AF4-driven leukemia is a distinct entity, with a unique gene expression profile showing significant overlap with stem cell programs and enhanced H3K79 methylation at known stem-cell associated genes such as HOXA9, MEIS1, and FLT3 [21, 29]. The gene discussed is KMT2A; the disease is leukemia.